Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

SELVAS Healthcare, Inc. (208370.KQ)

Compare
4,205.00
+55.00
+(1.33%)
At close: April 4 at 3:30:30 PM GMT+9
Loading Chart for 208370.KQ
  • Previous Close 4,150.00
  • Open 4,075.00
  • Bid 4,135.00 x --
  • Ask 4,210.00 x --
  • Day's Range 4,005.00 - 4,205.00
  • 52 Week Range 3,425.00 - 6,280.00
  • Volume 128,859
  • Avg. Volume 1,020,115
  • Market Cap (intraday) 108.143B
  • Beta (5Y Monthly) -0.79
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1999 and is headquartered in Daejeon, South Korea.

www.selvashealthcare.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 208370.KQ

View More

Performance Overview: 208370.KQ

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

208370.KQ
3.70%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

208370.KQ
20.81%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

208370.KQ
7.13%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

208370.KQ
95.13%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 208370.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 208370.KQ

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    108.14B

  • Enterprise Value

    85.05B

  • Trailing P/E

    34.47

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.43

  • Price/Book (mrq)

    1.70

  • Enterprise Value/Revenue

    2.68

  • Enterprise Value/EBITDA

    18.56

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.94%

  • Return on Assets (ttm)

    2.99%

  • Return on Equity (ttm)

    5.09%

  • Revenue (ttm)

    31.7B

  • Net Income Avi to Common (ttm)

    3.15B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    26.09B

  • Total Debt/Equity (mrq)

    4.70%

  • Levered Free Cash Flow (ttm)

    862.78M

Research Analysis: 208370.KQ

View More

Company Insights: 208370.KQ

Research Reports: 208370.KQ

View More

People Also Watch